Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
Inflamm Bowel Dis
; 28(1): 150, 2022 Jan 05.
Article
in En
| MEDLINE
| ID: mdl-34636902
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Inflamm Bowel Dis
Journal subject:
GASTROENTEROLOGIA
Year:
2022
Type:
Article
Affiliation country:
Spain